Shibata, Tatsuhiro
National Cancer Center Japan,
Japan
2025 Rank: 27248
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 814 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 27248 | 28768 |
| Total Cites | 4209 | 4650 |
| H-index | 28 | 30 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 107 | 114 |
| Number of Single+First+Last Authored Papers | 66 | 66 |
| Total Cites to Single+First+Last Authored Papers | 508 | 534 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3448 | 3682 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.26 |
| Self-Citation Percentage |
9.48%
|
|
Shibata, Tatsuhiro
The University of Tokyo,
Japan
2024 Rank: 18015
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 581 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 18015 | 17731 |
| Total Cites | 4402 | 4915 |
| H-index | 29 | 32 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 108 | 112 |
| Number of Single+First+Last Authored Papers | 66 | 66 |
| Total Cites to Single+First+Last Authored Papers | 530 | 568 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3546 | 3804 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.29 |
| Self-Citation Percentage |
10.44%
|
|
Shibata, Tatsuhiro
The Institute of Medical Science, The University of Tokyo,
Japan
2023 Rank: 21162
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 756 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 21162 | 22404 |
| Total Cites | 4544 | 5003 |
| H-index | 24 | 25 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 134 | 140 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 606 | 636 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3651 | 3888 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.29 |
| Self-Citation Percentage |
9.17%
|
|
Shibata, Tatsuhiro
National Cancer Center Research Institute,
Japan
2022 Rank: 20765
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 778 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 20765 | 21803 |
| Total Cites | 4573 | 5031 |
| H-index | 27 | 28 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 126 | 135 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 670 | 702 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3690 | 3931 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.28 |
| Self-Citation Percentage |
9.10%
|
|
Shibata, Tatsuhiro
National Cancer Center Research Institute,
Japan
2021 Rank: 28349
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 1024 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 28349 | 31346 |
| Total Cites | 6306 | 6958 |
| H-index | 32 | 33 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 232 | 246 |
| Number of Single+First+Last Authored Papers | 56 | 56 |
| Total Cites to Single+First+Last Authored Papers | 968 | 1016 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5183 | 5524 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.26 |
| Self-Citation Percentage |
9.37%
|
|
Shibata, Tatsuhiro
National Cancer Center Research Institute,
Japan
2020 Rank: 25299
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 890 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25299 | 28842 |
| Total Cites | 3889 | 4240 |
| H-index | 27 | 27 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 180 | 183 |
| Number of Single+First+Last Authored Papers | 56 | 56 |
| Total Cites to Single+First+Last Authored Papers | 676 | 700 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3286 | 3510 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.21 |
| Self-Citation Percentage |
8.28%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.